Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 monoclonal antibody therapy trial for patients with recurrent Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 1 | Status: COMPLETED